Hjem › Hjertesvikt › Tennessee › Nashville
Kliniske studier for Hjertesvikt i Nashville, TN
19 studier for Hjertesvikt søker deltakere på steder i og rundt Nashville (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Rekrutterer
- St.Thomas Health, Nashville
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
RekruttererFase 2
- Vanderbilt University Medical Center, Nashville
ELEVATE-HFpEF Clinical Study
Rekrutterer
- Saint Thomas Research Institute, Nashville
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
RekruttererFase 3
- Research Site, Nashville
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
RekruttererFase 3
- Vanderbilt University Medical Center, Nashville
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
RekruttererFase 3
- Research Site, Nashville
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
RekruttererFase 3
- Nashville, TN Investigative Site 10071, Nashville
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
RekruttererObservasjonsstudie
- Vanderbilt University, Nashville
Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy
RekruttererFase 1
- Vanderbilt University Medical Center, Nashville
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
RekruttererObservasjonsstudie
- Nashville, Nashville
A Prospective Registry Study to Assess Real-world Patient Characteristics, Treatment Patterns, and Longitudinal Outcomes in Patients Receiving Mavacamten and Other Treatments for Symptomatic Obstructive Hypertrophic Cardiomyopathy (Obstructive-HCM)
RekruttererObservasjonsstudie
- Tristar Centennial Medical Ctr, Nashville
- Saint Thomas Health, Nashville
LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
RekruttererFase 3
- Tenax Investigational Site, Nashville
OPtimal Adult Heart Transplant Immunosuppression With MicroRNA Levels
RekruttererObservasjonsstudie
- Vanderbilt University, Nashville
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Rekrutterer
- Vanderbilt, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Vanderbilt University Medical Center, Nashville
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Rekrutterer
- Centennial Medical Center, Nashville
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Rekrutterer
- Vanderbilt University Medical Center, Nashville
Wearable Technology to Evaluate Hyperglycemia and HRV in DMD - Longitudinal Aim
RekruttererObservasjonsstudie
- Vanderbilt University Medical Center, Nashville
AN INTERNATIONAL, OBSERVATIONAL, BLINDED STUDY TO ASSESS THE PERFORMANCE OF THE CORDIO HEARO SYSTEM
RekruttererObservasjonsstudie
- Vanderbilt University Medical Center, Nashville
Hjertesvikt-studier i andre byer
- New York City, NY51 studier
- Boston, MA44 studier
- Dallas, TX42 studier
- Houston, TX36 studier
- Cleveland, OH33 studier
- Chicago, IL31 studier
- Philadelphia, PA31 studier
- San Francisco, CA29 studier
- Durham, NC26 studier
- St. Louis, MO26 studier
- Atlanta, GA25 studier
- Kansas City, MO25 studier
Andre studier i Nashville
- Ikke-småcellet lungekreft97 studier
- Brystkreft81 studier
- Metastatisk kreft70 studier
- Kolorektal kreft69 studier
- Kreft (alle typer)65 studier
- Eggstokkreft49 studier
- Prostatakreft43 studier
- Lungekreft40 studier
- Plateepitelcancer i hode og hals39 studier
- Pankreaskreft39 studier
- Endometriekreft38 studier
- Melanom33 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.